SCHEMBL2879111

SCHEMBL2879111

CC1CCC(C(=O)N(c2cc(-c3ccc(F)cc3)sc2OC(=O)O)C2CCC(O)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.37
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
KDM4E B2RXH2 2/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
CHUK O15111 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
PTPN1 P18031 1/20 0.30
LMNA P02545 1/20 0.30
CYP46A1 Q9Y6A2 1/20 0.30
HTR2A P28223 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878752 0.92 GRM5 (0.35) KDM4EPOLBHTTATM
SCHEMBL2874208 0.91 KDM4E (0.38) CNR1CNR2KDM4EMAPTHTT
SCHEMBL2877206 0.91 KDM4E (0.38) CNR1CNR2KDM4EMAPTHTT
SCHEMBL2874240 0.91 KDM4E (0.38) CNR1CNR2KDM4EMAPTHTT
SCHEMBL2876896 0.90 NR1I2 (0.31)
SCHEMBL2881302 0.90 HSD17B1 (0.34) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2874941 0.89 NPC1 (0.36) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2878697 0.89 HDAC6 (0.31)
SCHEMBL2879246 0.88 HDAC1 (0.32) KDM4EHTTATM
SCHEMBL2871039 0.87 IKBKB (0.42) IKBKBKDM4ENPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed